Top Story

Top five dermatology stories in July include psoriasis studies, FDA approval

July 31, 2017

Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the top read articles in July on

Other widely-read articles included the FDA’s approval of Tremfya for treating adults with moderate-to-severe psoriasis who are candidates for systemic therapy or phototherapy, and research finding that patients with lung cancer who received immunotherapy experienced hair repigmentation:

In the Journals

Causal agents correlated with eyelid allergic dermatitis

July 28, 2017
A study investigating the causes of eyelid allergic dermatitis found a common correlation with glaucoma medications, topical cosmetics and skin care products. A short…
In the Journals

Cosmetic surveillance needs improvement

June 26, 2017
Because cosmetic manufacturers are not legally obligated to report adverse events to the FDA, people may experience serious health outcomes related to cosmetics;…
Meeting News

Query patients on makeup application, removal habits

June 12, 2017
A recent survey found that respondents who did not report using an eye makeup remover had higher Standardized Patient Evaluation of Eye Dryness scores than those who…
More Headlines »